In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home
Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular D...
Gespeichert in:
Veröffentlicht in: | Neurochemical research 2020-06, Vol.45 (6), p.1335-1343 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1343 |
---|---|
container_issue | 6 |
container_start_page | 1335 |
container_title | Neurochemical research |
container_volume | 45 |
creator | Fagan, Rita R. Kearney, Patrick J. Melikian, Haley E. |
description | Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT’s response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions. |
doi_str_mv | 10.1007/s11064-020-03001-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7261626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2407709502</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-ea299fe7dacb6940e515c60e983ea49ece9f63383d0244d24d1d61083ae4bbaa3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi1ERYfCC7BAltiwSTm-xB6zQEKltJVGUMGwtjzOydRtEk_tBKk7XoPX40nwMG25LFjZ0v_59zn6CHnG4JAB6FeZMVCyAg4VCABWqQdkxmotKmVAPCQzECUWzMA-eZzzZUEAOHtE9gVnUimpZ-T8bKCfwzjRT7ieOjdiQ9_FjevDgHSZ3JA3MY2Ytve2Df4qDOvXdHmBCX98-57ph0jPO-eRLsIV0tPY4xOy17ou49Pb84B8eX-8PDqtFh9Pzo7eLiovtRwrdNyYFnXj_EoZCViz2itAMxfopEGPplVCzEUDXMqGy4Y1isFcOJSrlXPigLzZ9W6mVY-Nx2FMrrObFHqXbmx0wf6dDOHCruNXq7liiqtS8PK2IMXrCfNo-5A9dp0bME7ZcqHrmnEGpqAv_kEv45SGsp7lErQGUwMvFN9RPsWcE7b3wzCwW2F2J8wWYfaXMLud4vmfa9w_uTNUALEDcomGNabff_-n9idGn6Fy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2407709502</pqid></control><display><type>article</type><title>In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Fagan, Rita R. ; Kearney, Patrick J. ; Melikian, Haley E.</creator><creatorcontrib>Fagan, Rita R. ; Kearney, Patrick J. ; Melikian, Haley E.</creatorcontrib><description>Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT’s response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions.</description><identifier>ISSN: 0364-3190</identifier><identifier>EISSN: 1573-6903</identifier><identifier>DOI: 10.1007/s11064-020-03001-6</identifier><identifier>PMID: 32146647</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Brain - metabolism ; Cell Biology ; Dopamine ; Dopamine - metabolism ; Dopamine Plasma Membrane Transport Proteins - metabolism ; Dopamine transporter ; GABA Plasma Membrane Transport Proteins - metabolism ; Humans ; Motivation ; Neurochemistry ; Neurology ; Neurosciences ; Original Paper ; Protein Transport - physiology ; Reinforcement ; Signal Transduction - physiology ; Signaling ; Trafficking</subject><ispartof>Neurochemical research, 2020-06, Vol.45 (6), p.1335-1343</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-ea299fe7dacb6940e515c60e983ea49ece9f63383d0244d24d1d61083ae4bbaa3</citedby><cites>FETCH-LOGICAL-c474t-ea299fe7dacb6940e515c60e983ea49ece9f63383d0244d24d1d61083ae4bbaa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11064-020-03001-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11064-020-03001-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32146647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fagan, Rita R.</creatorcontrib><creatorcontrib>Kearney, Patrick J.</creatorcontrib><creatorcontrib>Melikian, Haley E.</creatorcontrib><title>In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home</title><title>Neurochemical research</title><addtitle>Neurochem Res</addtitle><addtitle>Neurochem Res</addtitle><description>Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT’s response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions.</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain - metabolism</subject><subject>Cell Biology</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Plasma Membrane Transport Proteins - metabolism</subject><subject>Dopamine transporter</subject><subject>GABA Plasma Membrane Transport Proteins - metabolism</subject><subject>Humans</subject><subject>Motivation</subject><subject>Neurochemistry</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Original Paper</subject><subject>Protein Transport - physiology</subject><subject>Reinforcement</subject><subject>Signal Transduction - physiology</subject><subject>Signaling</subject><subject>Trafficking</subject><issn>0364-3190</issn><issn>1573-6903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kctu1DAUhi1ERYfCC7BAltiwSTm-xB6zQEKltJVGUMGwtjzOydRtEk_tBKk7XoPX40nwMG25LFjZ0v_59zn6CHnG4JAB6FeZMVCyAg4VCABWqQdkxmotKmVAPCQzECUWzMA-eZzzZUEAOHtE9gVnUimpZ-T8bKCfwzjRT7ieOjdiQ9_FjevDgHSZ3JA3MY2Ytve2Df4qDOvXdHmBCX98-57ph0jPO-eRLsIV0tPY4xOy17ou49Pb84B8eX-8PDqtFh9Pzo7eLiovtRwrdNyYFnXj_EoZCViz2itAMxfopEGPplVCzEUDXMqGy4Y1isFcOJSrlXPigLzZ9W6mVY-Nx2FMrrObFHqXbmx0wf6dDOHCruNXq7liiqtS8PK2IMXrCfNo-5A9dp0bME7ZcqHrmnEGpqAv_kEv45SGsp7lErQGUwMvFN9RPsWcE7b3wzCwW2F2J8wWYfaXMLud4vmfa9w_uTNUALEDcomGNabff_-n9idGn6Fy</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Fagan, Rita R.</creator><creator>Kearney, Patrick J.</creator><creator>Melikian, Haley E.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200601</creationdate><title>In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home</title><author>Fagan, Rita R. ; Kearney, Patrick J. ; Melikian, Haley E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-ea299fe7dacb6940e515c60e983ea49ece9f63383d0244d24d1d61083ae4bbaa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain - metabolism</topic><topic>Cell Biology</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Plasma Membrane Transport Proteins - metabolism</topic><topic>Dopamine transporter</topic><topic>GABA Plasma Membrane Transport Proteins - metabolism</topic><topic>Humans</topic><topic>Motivation</topic><topic>Neurochemistry</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Original Paper</topic><topic>Protein Transport - physiology</topic><topic>Reinforcement</topic><topic>Signal Transduction - physiology</topic><topic>Signaling</topic><topic>Trafficking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fagan, Rita R.</creatorcontrib><creatorcontrib>Kearney, Patrick J.</creatorcontrib><creatorcontrib>Melikian, Haley E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurochemical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fagan, Rita R.</au><au>Kearney, Patrick J.</au><au>Melikian, Haley E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home</atitle><jtitle>Neurochemical research</jtitle><stitle>Neurochem Res</stitle><addtitle>Neurochem Res</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>45</volume><issue>6</issue><spage>1335</spage><epage>1343</epage><pages>1335-1343</pages><issn>0364-3190</issn><eissn>1573-6903</eissn><abstract>Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT’s response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32146647</pmid><doi>10.1007/s11064-020-03001-6</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-3190 |
ispartof | Neurochemical research, 2020-06, Vol.45 (6), p.1335-1343 |
issn | 0364-3190 1573-6903 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7261626 |
source | MEDLINE; SpringerLink Journals |
subjects | Animals Biochemistry Biomedical and Life Sciences Biomedicine Brain - metabolism Cell Biology Dopamine Dopamine - metabolism Dopamine Plasma Membrane Transport Proteins - metabolism Dopamine transporter GABA Plasma Membrane Transport Proteins - metabolism Humans Motivation Neurochemistry Neurology Neurosciences Original Paper Protein Transport - physiology Reinforcement Signal Transduction - physiology Signaling Trafficking |
title | In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A20%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Situ%20Regulated%20Dopamine%20Transporter%20Trafficking:%20There%E2%80%99s%20No%20Place%20Like%20Home&rft.jtitle=Neurochemical%20research&rft.au=Fagan,%20Rita%20R.&rft.date=2020-06-01&rft.volume=45&rft.issue=6&rft.spage=1335&rft.epage=1343&rft.pages=1335-1343&rft.issn=0364-3190&rft.eissn=1573-6903&rft_id=info:doi/10.1007/s11064-020-03001-6&rft_dat=%3Cproquest_pubme%3E2407709502%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2407709502&rft_id=info:pmid/32146647&rfr_iscdi=true |